Radiation, chemotherapy and surgery don’t cut it against glioblastoma, an aggressive type of brain cancer that often recurs with a vengeance. Ziopharm is working on a “remote-controlled” gene therapy to buy these patients more time—and early data show it extended patients’ lives by more than a year.